Evolution of cancer etiology and primary prevention. by Tomatis, L & Huff, J
Editorial
Primary prevention, broadly defined as the protection of health by
personal and community-wide efforts (1), consists of measures aimed
at preventing the inception of a pathologic process or the occurrence
of a disease, in contrast with secondary prevention that consists of
measures for the early detection and prompt intervention on a clini-
cally asymptomatic disease. Referring to cancer, primary prevention
mainly involves the avoidance or drastic reduction of exposure to
carcinogenic risk factors.
Primary prevention of cancer has evolved through the ages, in
close relation to the evolution in our understanding and interpreta-
tion of cancer etiology. In ancient times etiology and prevention of
cancer were entirely included within the concept of this feared disease
being equivalent to divine punishment. Recognition of one’s sins,
repentance, and pious obedient behavior opened the only available
path to God’s forgiveness and provided the only possible protection
from cancer. Traces of such belief are still with us, not only as remain-
ders of old superstitions but also as components of today’s attribution
of a prominent role in the origin of disease to individual behaviors,
habits, and lifestyles. Individual behavior and lifestyle certainly play
important roles, but today’s trend appears to be that individuals are
considered not only responsible for but also guilty of causing their
disease, a situation very close to suffering the curse of God.
The spectrum of diseases considered to be self-inflicted is wide,
ranging from those related to the use of tobacco to excessive alcohol
consumption and from overnutrition to lack of exercise. However,
the assumption that all behavioral choices are free choices does not
reflect the actual situation. Apart from the obvious fact that certain
individuals may be genetically predisposed to some conditions, the
commonly used term “lifestyle” does not distinguish the various caus-
es of habitual behavior, such as smoking, alcohol drinking, unhealthy
dietary habits, and lack of physical exercise. Among these causes,
social pressures and ubiquitous advertising play an essential role (2).
Only a minority of inner-directed, strong-willed people can oppose or
resist such pressures and make fully autonomous choices. Moreover
individuals cannot really choose the socioeconomic situation in which
to be born or their genetic background, and most workers cannot
choose to avoid working in hazardous industries or occupations. 
The only time that cancer was considered to be transmissible was
between the seventeenth and eighteenth centuries. Special hospitals
were built in certain European countries to isolate patients with can-
cer, almost in the same way as was done for patients with leprosy (3).
Relatively soon, however, the conviction that cancer was not conta-
gious prevailed again. It was strengthened during the glorious period
of microbiology by the inability to identify a germ or bacterium that
could be related to cancer. This may perhaps partly explain the scant
attention paid to the experiments of Peyton Rous (4) at the beginning
of the twentieth century on the role of viruses in the origin of tumors.
In the first half of the twentieth century, the hypothesis of a viral ori-
gin for human cancer gained the support of great scientists such as
Oberling in France and Zilber in the former Soviet Union (5). It
became a favorite hypothesis at the time of President Nixon’s war
against cancer in the early 1970s, and has recently returned to the
stage with renewed strength (6).
Besides the hypothesis of infectious (parasitic or viral) etiology,
other early prevailing speculations on the origins of cancer have been
the cell irritation theory, proposed by Virchow, and the embryonic
“cell rest” theory of Conheim, who proposed that tumors arise from
embryonic cells that fail to mature and persist in the tissues (3,7–9).
Of more than anecdotal interest may be that the 1905 report of the
Huntington Cancer Research Fund, noting the unsuccessful attempts
made to identify the causes of cancer, stated that “It has therefore
seemed advisable … to branch out into new methods, and attempt to
investigate, not so much the cause of cancer as the conditions under
which it may arise” with the “hope that by collecting a number of
data a deeper insight into the question may ultimately be obtained,
and a nearer approach be made to a conception of the nature of the
processes involved” (8). In spite of the obviously different levels of
knowledge and the magnitude of progress, the predominant trend in
cancer research today could be described in not too dissimilar words.
For many decades there was a strong rivalry between proponents
of chemical carcinogenesis and of viral carcinogenesis that was based
partly on different schools of thought, but this rivalry was also largely
related to competition for research funds. Scientists in the field of
viral carcinogenesis, and later of molecular biology, were generally of
the opinion that those involved in chemical carcinogenesis were old-
fashioned and perhaps also not particularly brilliant (10–12), while
those working in chemical carcinogenesis looked with skepticism at
viral oncologists. In terms of funding and popularity, chemical car-
cinogenesis prevailed until the late 1960s and early 1970s. Then came
Nixon’s declaration of war against cancer that led to the belief that the
dread disease could be conquered with the same kind of concerted
effort that split the atom and landed humans on the moon. The search
for a viral etiology of human cancer was launched as a glorious chal-
lenge, and viral carcinogenesis, in particular the studies on the viral ori-
gin of human leukemia, obtained considerable increases in funding.
5 VOLUME 109 | NUMBER 10 | October 2001 • Environmental Health Perspectives
Evolution of Cancer Etiology and
Primary Prevention
PERSPECTIVES
Editorial
Primary prevention aimed at avoiding or drastically reducing exposures will be the most
efficient way to prevent environmentally associated cancers.
James Huff and Lorenzo Tomatis6 VOLUME 109 | NUMBER 10 | October 2001 • Environmental Health Perspectives
Editorial
The causes of cancer have been divided roughly into two broad
categories: exogenous (or environmental) and endogenous (or genet-
ic), a division that has been operationally useful because it favored the
concentration and funding of efforts that, on the basis of technology
and methods available at the time, offered the greatest possibility of
success. For a long time, this meant that the prevailing area of cancer
research focused on the identification of exogenous environmental,
and for a long time mainly occupational, causes of human cancer.
Expansion of research on environmental and occupational causes of
cancer also coincided with, and possibly contributed to, growing
awareness of the relationships between socioeconomic conditions and
health, and to a tendency toward decreasing the inequalities in health
care and services. However, not much progress has been made toward
actually reaching a greater social and health equity worldwide (13,14).
The first environmental agents to be identified as human car-
cinogens were tobacco snuff (15), a life habit related to habitual con-
sumption, and chimney soot (16), which is related to occupational
exposures. A century later, they were followed by arsenic used in
therapy (17), aromatic amines (18), and thereafter by a long series of
chemicals or chemical mixtures that, for the most part, were found
to be human carcinogens in the working environment (19). All of
these agents were identified on the basis of clinical observations, case
reports, or epidemiologic studies. Most of these carcinogens were
actually identified in situations that, to a considerable extent,
mimicked experimental conditions of long-term carcinogenicity
bioassays: relatively small population groups exposed to high concen-
trations of hazardous agents in a closed environment. The carcino-
gens identified in the working environment were called occupational
carcinogens, a term that was often interpreted to imply that their car-
cinogenicity was not only directly related but also limited to the
occupational setting. However, agents that were identified as human
carcinogens within the working environment (e.g., benzene,
asbestos) do not cease to be carcinogenic when encountered at lower
concentrations in the general environment, often for long periods. 
Ionizing radiation is another prominent environmental agent
identified as being carcinogenic at the beginning of the twentieth
century. Ionizing radiation was discovered by Roentgen in 1895
(20) and introduced into medical practice soon thereafter. It took
only 7 years for scientists to determine and report that ionizing radi-
ation induced tumors in exposed individuals (21,22). This was a
particularly short delay, compared with the much longer periods
required for the recognition of chemicals introduced into the envi-
ronment as human carcinogens. However, in spite of the rapidity
with which the awareness of radiation carcinogenicity was acquired,
it was 40 more years before it became accepted that natural radioac-
tivity present in uranium mines was also carcinogenic (23). Further,
several decades elapsed before it became officially recognized that
radioactivity in the general environment at much lower concentra-
tions also represented a carcinogenic risk (24). Ionizing radiation
thus provides a pertinent example of how long the stepwise process
can last beginning with the scientific observation of the carcino-
genicity of an environmental agent to the official recognition of a
cancer risk to humans at both high and low levels of exposure. 
As a matter of fact, in spite of the convincing evidence of their
carcinogenicity, the adoption of measures to avoid exposure to
even the most obvious carcinogenic hazards has encountered con-
tinued and serious obstacles and unjustified delays. Aromatic
amines were shown to be carcinogenic in exposed workers at the
end of the nineteenth century (18) and the International Labour
Office officially declared benzidine and 2-naphthylamine as human
carcinogens in 1921 (25), but the first official action toward phas-
ing out these aromatic amines was not taken until the late 1960s.
The first report of an increased risk for lung cancer in workers
exposed to bischloromethylether is dated 1962, but no action was
taken, under various pretexts, until 1975 (26). Many other exam-
ples pertain as well. More recently, in 1985 the National Tox-
icology Program (NTP) showed that 1,3-butadiene was a potent
carcinogen at 6.5 ppm and most likely below that level of exposure,
and yet the occupational exposure standard was not lowered until
November 1996 (27,28).
Legislation prohibiting the manufacture of a limited number of
chemicals identified as human carcinogens was introduced in the late
1960s in several industrialized countries, but did not cover the same
chemical carcinogens in each country. In addition, the criteria to
determine which chemicals may be hazardous to humans on the
basis of the experimental evidence of carcinogenicity varied consider-
ably from country to country and were, in general, overly exclusive
(29,30). Nevertheless, due to the combined effect of banning or
reducing exposure to certain carcinogens, the modernization of
many industrial production processes, the overall reduction of the
number of industrial workers, and the transfer of hazardous indus-
tries to developing countries, the number of occupational cancers has
decreased in most industrialized countries. However, occupational
cancers are now becoming a very serious problem in developing
countries where industrialization is a rather recent phenomenon and
where exposure levels to hazardous chemicals considerably exceed
regulatory levels established in industrialized countries (31,32).
Because most human carcinogens that have been identified within
the first half of the twentieth century were occupational carcinogens,
prevention of human cancer became focused on eliminating, or
reducing to a minimum, occupational exposures to identified human
carcinogens. During that same period results from long-term animal
bioassays provided evidence for the carcinogenicity of additional
chemicals, and attempts were made to deal with these carcinogenic
agents as if they were de facto human carcinogens (19,33,34). The
International Agency for Research on Cancer (35) recommended that 
“in the absence of adequate data on humans, it is biologically plausible and
prudent to regard agents and mixtures for which there is sufficient evidence
of carcinogenicity in experimental animals as if they presented a carcinogenic
risk to humans.” 
Likewise, the NTP considers chemicals shown to be carcinogenic in
animals without any human evidence as being “reasonably anticipated
to be carcinogenic to humans” (36).
The credibility of experimental results as effective predictors of
human risk was systematically questioned by industry. The industry
point of view was supported by numerous scientists, either because
they had working or financial relations with industry or because, in
good faith, they asked for a degree of certainty greater than the
available methods could actually provide. In parallel, regulatory
agencies and health authorities often pretended a full assurance that
findings of experimental studies were truly predictive of similar out-
comes in humans, whereas doubtful or inadequate negative epi-
demiologic observations were sometimes inappropriately considered
as more relevant than positive experimental results (37). As a conse-
quence, in spite of the fact that sufficient information was available
for its implementation on a wide scale, primary prevention has con-
tinued to encounter serious obstacles and unjustifiable delays.
Research on the endogenous component of the carcinogenesis
process gained importance and gradually took over when methods of
molecular biology began to be applied to cancer research. Cancer
virology, which received a generous share of the funds made available
by the Nixon administration, did not produce the hoped-for solu-
tion to the cancer riddle, but it did contribute to the development of
scientists with new skills. These scientists became essential to the
rapid development of molecular biology and molecular genetics and
thus played an important role in the shift of scientific interest. 
This was probably one of the most significant (albeit unintend-
ed) results from the war on cancer. Even the strongest traditional
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disciplines, such as biochemistry and pathology and more recently
epidemiology, are now becoming “molecular.” In parallel with the
growing role of research on the endogenous and genetic causes of can-
cer and, above all, on the mechanisms underlying the carcinogenesis
processes, interest in the role of socioeconomic factors and public
health as a whole has decreased (13). Genetics is, however, also the
study of how memories of the past are preserved in our genes and
of the way such memories sway interactions with the present and
future. This is perhaps one of the few good auspices for the future
in a period that seems to be dominated by attempts to suppress his-
tory and memories.
For many decades primary prevention of cancer was implement-
ed on the basis of evidence for a causal relationship between an
exposure and human cancer that took into consideration biological
plausibility, but was independent from any degree of understanding
of underlying mechanisms. One of the credos of public health has
been that prevention can be implemented before having established
causality or before reaching a complete understanding of mecha-
nisms. The rapid development and expansion of molecular biology
and molecular genetics has provided methods and tools that permit
investigations of some of the finer details of the carcinogenesis
processes. A deeper knowledge of mechanisms may allow future
interventions aimed at stopping the sequence of events leading to
tumor development, invasiveness, and metastases and may substan-
tially improve therapeutic interventions. However, at present, the
emphasis on research into the pathogenesis of cancer seems to have
encouraged an almost complete, hopefully temporary, elimination
of reliance and research on etiology and prevention. 
From a period in which cancer causes, or components of causes,
were identified with little understanding of the underlying mecha-
nisms, we have entered a period in which the understanding of
mechanisms progresses rapidly without as yet contributing to the
identification of new carcinogenic agents or the definition of prima-
ry prevention strategies. In this context, a most urgent and compli-
cated issue is development of a better understanding of the role of
low-level exposures to multiple risk factors and of the extent and
nature of their possible interaction. The most reasonable and social-
ly acceptable development of prevention should be the blending of
the population approach (i.e., a shifting of the distribution of risk
factors across an entire population in a favorable direction) with the
high-risk approach (i.e., the intervention on individuals predisposed
to the disease) (38). Interventions aimed at reducing or eliminating
genetically determined weaknesses in the interaction with the envi-
ronment will, therefore, not in any way make obsolete or redundant
interventions aimed at eliminating or reducing exposures to envi-
ronmental carcinogens and at improving socioeconomic conditions
(39). Exposure to environmental carcinogens causes cancer, and it is
therefore obvious that measures of primary prevention aimed at
avoiding or drastically reducing exposures will be the most efficient
way to prevent environmentally associated cancers. In addition, pri-
mary prevention by protecting the health of all individuals has an
intrinsic characteristic of universality that diagnostic and therapeutic
approaches do not have because they may unavoidably introduce a
potential for discrimination on socioeconomic grounds.
Furthermore, suggested priorities centered on primary prevention
are clearly in keeping with the precautionary principle (40). 
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